"Knowledge is power. Data sharing is an important way to gain the knowledge we need to learn how our genomes affect our health. That power will allow us to improve health once and for all."
Sherri Bale received her B.A. in Biology from Clark University, her M.S. and Ph.D. degrees from the University of Pittsburgh, and her post-doctoral training in medical genetics at the National Institutes of Health, Bethesda, MD. She is an ABMG Board-Certified Ph.D.- Medical Geneticist and Founding Member of the American College of Medical Genetics, served on the ACMG Professional Practice and Guidelines Committee, the ACMG Foundation Committee, the Corporate Responsibility Task Force, co-chaired the Whole Exome/Genome Sequencing Task Force, and works with the Laboratory Practice Committee. She is a consultant to various academic, federal, and private organizations regarding clinical, technical, and regulatory issues in genetics and genetic testing. She co-founded GeneDx in 2000 after 16 years at the National Institutes of Health. GeneDx was acquired by BioReference Laboratories, Inc. in 2006. Dr. Bale served as President and Clinical Director of GeneDx until 2011, and then became Managing Director of GeneDx and Sr. Vice President of BioReference Laboratories. The company specializes in developing and providing molecular diagnostic tests for hereditary genetic disease using innovative methods. Dr. Bale has authored 140 peer-reviewed papers, book chapters, and books in the field of genetics. She serves as President of the Board of Directors of an international adoption agency that specializes in placing older and special needs children. She holds a second degree black belt in judo.